Template:Hyperphosphatemia treatment: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
===[[Hyperphosphatemia]] treatment=== | ===[[Hyperphosphatemia]] treatment=== | ||
*'''Treat the underlying cause''' | |||
*Restrict calcium phosphate intake | |||
*IV Normal Saline (if normal renal fx) | |||
*[[Acetazolamide]] (500mg IV q6hr) - if normal renal function | |||
*Phosphate Binder - Aluminum hydroxide (50-150mg/kg PO q4-6h) - limited effect | |||
*Dialysis if refractory | |||
Latest revision as of 19:09, 25 August 2019
Hyperphosphatemia treatment
- Treat the underlying cause
- Restrict calcium phosphate intake
- IV Normal Saline (if normal renal fx)
- Acetazolamide (500mg IV q6hr) - if normal renal function
- Phosphate Binder - Aluminum hydroxide (50-150mg/kg PO q4-6h) - limited effect
- Dialysis if refractory